PB1794: NATURAL FLAVONOIDS INHIBIT MYELOID NEOPLASM PROLIFERATION BY REGULATING PIM2 KINASE ACTIVITY

PB1794: NATURAL FLAVONOIDS INHIBIT MYELOID NEOPLASM PROLIFERATION BY REGULATING PIM2 KINASE ACTIVITY

Bibliographic Details
Main Authors:	Hao Wang, Zhaoyun Liu, Rong Fu
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000974032.43933.a2

Similar Items

An overview of pim kinase as a target in multiple myeloma
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA
by: Zhaoyun Liu, et al.
Published: (2023-08-01)

Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
by: Zhaoyun Liu, et al.
Published: (2022-12-01)

PB1778: PAN-PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI-LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA
by: Chi-Yang Tseng, et al.
Published: (2023-08-01)

PB1794: EFFECT OF HYPOXIA ON CD47 EXPRESSION IN HUMAN ACUTE MYELOID LEUKEMIA CELL LINES
by: C. Wang, et al.
Published: (2022-06-01)

PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma
by: Janet R. Julson, et al.
Published: (2023-12-01)

PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01)

Pim Kinases: Important Regulators of Cardiovascular Disease
by: Sophie Nock, et al.
Published: (2023-07-01)

PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
by: Chi-Yang Tseng, et al.
Published: (2023-08-01)

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
by: Teresa Paíno, et al.
Published: (2020-09-01)

PB1910: CHRONIC MYELOID LEUKEMIA AND RELATIONSHIP TO SECONDARY SOLID NEOPLASMS
by: M. J. Ramos, et al.
Published: (2022-06-01)

Structure and substrate specificity of the Pim-1 kinase.
by: Bullock, A, et al.
Published: (2005)

Structure and substrate specificity of the Pim-1 kinase
by: Bullock, A, et al.
Published: (2005)

The Role of PIM Kinases in Pediatric Solid Tumors
by: Janet Rae Julson, et al.
Published: (2022-07-01)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
by: Amber N. Clements, et al.
Published: (2022-11-01)

PIM kinases regulate early human Th17 cell differentiation
by: Tanja Buchacher, et al.
Published: (2023-12-01)

PB2180: TREATMENT CHALLENGES OF COEXISTING MYELOID AND LYMPHOID NEOPLASM- A CASE REPORT
by: Mihailo Smiljanic, et al.
Published: (2023-08-01)

Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
by: Bullock, A, et al.
Published: (2009)

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
by: Bataille, C, et al.
Published: (2017)

PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
by: Elisa Assirelli, et al.
Published: (2024-03-01)

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
by: Rachel K. Toth, et al.
Published: (2022-03-01)

Targeting Pim kinases in hematological cancers: molecular and clinical review
by: Marcia Bellon, et al.
Published: (2023-01-01)

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
by: Akué-Gédu, R, et al.
Published: (2009)

An Icelandic Noctuary of 1794
by: Már Jónsson
Published: (2020-12-01)

Condorcet (1743-1794)
by: Evans-Pritchard, EE
Published: (1972)

KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.
by: Fang Cheng, et al.
Published: (2009-03-01)

Extracellular Vesicles in Myeloid Neoplasms
by: Christina Karantanou, et al.
Published: (2022-08-01)

Ruthenium half-sandwich complexes bound to protein kinase Pim-1.
by: Debreczeni, J, et al.
Published: (2006)

Ruthenium half-sandwich complexes bound to protein kinase Pim-1
by: Debreczeni, J, et al.
Published: (2006)

PIM3 Kinase: A Promising Novel Target in Solid Cancers
by: Pinar Atalay, et al.
Published: (2024-01-01)

Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication
by: Madelaine Sugasti-Salazar, et al.
Published: (2022-02-01)

Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.
by: Akito Koike, et al.
Published: (2022-10-01)

Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis
by: Chao Lu, et al.
Published: (2022-09-01)

PB2031: NEXT GENERATION SEQUENCING IN MYELOID NEOPLASMS: DEVELOPING WORLD DATA FROM SINGLE CENTRE
by: Nida Anwar, et al.
Published: (2023-08-01)

Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm
by: Akash Gupta, et al.
Published: (2022-10-01)

STUDYING THE ROLE OF PIM KINASES IN FLT3-ITD-INDUCED LEUKEMIA REVEALED PIM1 AS REGULATOR OF CXCL12/CXCR4-MEDIATED HOMING AND MIGRATION
by: Brault, L, et al.
Published: (2009)

Dioscin suppresses proliferation and metastasis of osteosarcoma by inhibiting HuR/Pim1 axis via the induction of miR-16-5p level
by: Bo Jiang, et al.
Published: (2022-11-01)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
by: Bruno Fattizzo, et al.
Published: (2022-06-01)

Electrostatically Enhanced Association of a Pim Kinase Substrate Revealed by Stochastic Detection
by: Harrington, L, et al.
Published: (2014)

Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1.
by: Ekambaram, R, et al.
Published: (2013)